Egis Technology Inc. (TPEX:6462)

Verve Therapeutics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,954	16,106	8,875	4,191	8,036	11,915
Market Cap Growth	-52.21%	81.46%	111.78%	-47.84%	-32.56%	-26.84%
Enterprise Value	17,913	22,321	12,866	7,543	2,758	11,756
Last Close Price	131.00	176.50	119.50	58.98	99.92	134.61
PE Ratio	-	-	-	-	-	18.84
Forward PE	39.91	33.88	-	66.12	24.89	12.00
PS Ratio	2.46	3.36	2.31	1.27	2.33	1.91
PB Ratio	1.11	1.54	1.03	0.55	1.27	2.53
P/TBV Ratio	-	-	5.18	1.35	1.31	2.65
P/FCF Ratio	-	-	-	-	-	22.88
P/OCF Ratio	-	-	159.23	-	-	19.74
EV/Sales Ratio	3.69	4.66	3.34	2.29	0.80	1.89
EV/EBITDA Ratio	-	-	-	-	-	13.24
EV/EBIT Ratio	-	-	-	-	-	13.82
EV/FCF Ratio	-96.30	-	-	-	-	22.58
Debt / Equity Ratio	0.48	0.49	0.34	0.41	0.17	0.24
Debt / EBITDA Ratio	-	-	-	-	-	1.23
Debt / FCF Ratio	-	-	-	-	-	2.20
Asset Turnover	0.30	0.30	0.31	0.32	0.44	1.02
Inventory Turnover	5.05	4.20	2.16	1.90	4.19	6.16
Quick Ratio	0.57	0.56	1.12	1.29	2.72	2.28
Current Ratio	0.79	0.71	1.51	2.00	3.16	2.88
Return on Equity (ROE)	-16.99%	-14.51%	-12.36%	-12.92%	-4.20%	16.70%
Return on Assets (ROA)	-5.28%	-4.68%	-5.68%	-5.75%	-2.41%	8.71%
Return on Capital (ROIC)	-6.32%	-5.56%	-6.44%	-6.62%	-2.83%	10.67%
Return on Capital Employed (ROCE)	-	-	-	-	-	14.60%
Earnings Yield	-9.71%	-6.35%	-8.13%	-20.35%	-2.68%	5.31%
FCF Yield	-1.56%	-1.45%	-0.44%	-42.72%	-9.78%	4.37%
Dividend Yield	-	-	-	5.09%	10.01%	11.14%
Payout Ratio	-	-	-	-	-	98.57%
Buyback Yield / Dilution	-15.21%	-11.34%	-4.55%	-	0.48%	-0.51%
Total Shareholder Return	-	-11.34%	-4.55%	5.09%	10.49%	10.64%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.